Page last updated: 2024-10-31

metyrapone and Apudoma

metyrapone has been researched along with Apudoma in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Apudoma: A general term collectively applied to tumors associated with the APUD CELLS series, irrespective of their specific identification.

Research Excerpts

ExcerptRelevanceReference
"The Cushing's syndrome was controlled medically, and when the patient deteriorated clinically she received treatment with a combination of BCNU, adriamycin, and ftorafur."1.26Successful therapy of an ACTH-producing gastric carcinoid APUD tumor: report of a case and review of the literature. ( Callen, PW; Churg, A; Friedman, MA; Harbour, J; Marcus, FS, 1980)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marcus, FS1
Friedman, MA1
Callen, PW1
Churg, A1
Harbour, J1

Other Studies

1 other study available for metyrapone and Apudoma

ArticleYear
Successful therapy of an ACTH-producing gastric carcinoid APUD tumor: report of a case and review of the literature.
    Cancer, 1980, Sep-01, Volume: 46, Issue:5

    Topics: Adrenocorticotropic Hormone; Apudoma; Carcinoid Tumor; Cushing Syndrome; Cytoplasmic Granules; Femal

1980